For the male-specific cancer, prostate cancer, the final multivariable linear regression model showed that age at presentation, PSA level (ng/mL) and distant metastases (determined) were significantly associated with drug treatment costs. This evidence concerns the gene KLK3 and Familial prostate cancer.